Thanks for signing up for DividendStocks.com! It's the daily newsletter built for dividend and income investors. Before we can begin sending your daily updates, there’s one quick step left. Please confirm your subscription using the link below so our emails reach your inbox. Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Let’s get your dividend journey started! Discover Top Income-Generating Stocks Here See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
Exclusive Article from MarketBeat.com
Insider Trades: Okta and Abbott See Buys, Micron Insiders SellBy Leo Miller. Date Posted: 5/13/2026. 
Key Points
- Interesting insider trades have recently hit three key stocks experiencing very different near-term performance.
- Insiders are purchasing shares of cybersecurity stock Okta, and healthcare giant Abbott.
- Meanwhile, after a historically strong run, Micron's insider selling has increased in Q2.
- Special Report: Elon’s “Hidden” Company
Insiders are making moves in three stocks that have seen major swings in value in recent months. That includes insider buying in names that have fallen more than 30% and sales in one of the market’s hottest tech stocks. Here are the signals insiders are sending to investors in Q2. As AI Fears Weigh on Okta, an Insider Steps InFirst up is Okta (NASDAQ: OKTA), a stock that has struggled considerably. Compared with its 52-week high, Okta is down almost 40%. One of the key drivers has been fears about the effect artificial intelligence (AI) will have on the cybersecurity sector.
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings.
Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds.
If any of these are in your portfolio, now is the time to review your positions. See the 5 stocks to avoid
The market is running scared, driven by the idea that AI models will solve many of the problems cybersecurity companies have built businesses around. However, there is also an argument that, when put in the wrong hands, AI models increase cyber risk, potentially making these companies more important than ever. Amid Okta’s struggles, one insider is clearly showing confidence in the business. In Q2, Director David Schellhase purchased around $267,000 worth of Okta stock, a bullish indicator. Still, investors will notice that insider sales in Q2 have considerably outweighed his purchase, at $1.2 million. However, the details here are interesting. The sales and purchases both came under predetermined 10b5-1 plans. When it comes to 10b5-1 sales, the negative signal they send is somewhat limited, as they are often used by insiders simply to gain liquidity over time. On the other hand, insiders tend to buy their company’s stock only if they think the price will rise. As a result, 10b5-1 plan buys are still bullish, and potentially even more so than non-10b5-1 buys. They signal sustained conviction, as future purchases through this plan are likely to occur. Micron’s Insider Selling: Red Flag or Non-Issue?Micron Technology (NASDAQ: MU) was one of the market's best-performing stocks in 2025 and has continued to move sharply higher in 2026. After notching a 240% gain in 2025, shares have already appreciated more than 170% so far in 2026. The reason for Micron’s rise is well documented: memory chips are in short supply, while demand from AI data centers is intense. These dynamics have led to Micron posting some astonishing financial metrics. In its latest quarter, Micron’s revenue rose by 196% year over year (YOY) to a record $23.9 billion. Meanwhile, earnings per share rose by 682% YOY to $12.20. However, the company is also seeing some notable insider activity in Q2. Insider sales have approximately doubled from Q1, rising to $45 million versus $22 million last quarter. The company has also not seen any insider buys, compared with $7.8 million in buys during Q1. Still, the majority, or $35 million, of these sales came under a 10b5-1 plan. Sumit Sadana’s $10.1 million sale did not. However, Sadana’s sale was a moderate trim rather than an exit, representing around 10% of his holdings. Overall, while not positive, the mitigating factors make Micron’s recent sales not overly concerning. Abbott Insiders Send Bullish Signals as Shares Plummet in 2026Last up is Abbott Laboratories (NYSE: ABT), one of the world’s largest names in healthcare equipment and supplies. Abbott is another stock experiencing weakness, down more than 20% since the start of 2025 and down over 30% in 2026. Abbott’s recent earnings reports were significant contributors to the stock’s decline. In Q4 2025, Abbott posted mixed results, with in-line adjusted earnings per share (EPS) of $1.50 but revenue that fell below expectations by $342 million. The company’s guidance for 2026 was essentially in line with estimates. However, markets focused on the miss, pushing Abbott shares down 10% in reaction. Its Q1 2026 results saw top- and bottom-line beats, but Abbott lowered its full-year EPS guidance, leading shares to fall 6%. However, multiple insiders are picking up the slack in this stock, with total insider purchases of $1.13 million in Q2. This adds to buying in Q1, which came in at $1.09 million, and MarketBeat has tracked no insider sales in Q2 thus far. The uptick in purchases clearly coincides with Abbott’s significant 2026 decline, which has been a big drag on longer-term performance. This suggests insiders are buying what they likely see as a dip in Abbott stock, a positive sign going forward. Analysts Eye Solid Upside in Abbott Amid 2026 SlideTrades surrounding Micron do not send a strong signal. However, buys at Okta and Abbott are worth noticing. Importantly, investors should remember that insider transactions are just one tool for assessing the future of individual stocks. They are not declarations of how these names will move going forward. Still, Wall Street analysts are echoing the sentiment of insiders when it comes to Abbott. The MarketBeat consensus price target on shares near $119 implies more than 40% upside in the stock. Targets updated after the company’s latest earnings report are similarly bullish. The average of these targets is just slightly lower than the consensus, at approximately $118. |
0 Response to "Dividend Income Update"
Post a Comment